Review: The pharmacology of dobutamine

American Journal of the Medical Sciences

Volumn 294, Issue 4, 1987, Pages 244-248

  Ruffolo, R R ^a  

^a Department of Pharmacology Smith Kline & French Laboratories Swedeland PA 19479 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; ISOPRENALINE; NORADRENALIN; VASODILATOR AGENT;

CONGESTIVE HEART FAILURE; HUMAN; MAMMAL; NONHUMAN; REVIEW; DRUG EFFECT; HEART CONTRACTION; HEMODYNAMICS; PATHOPHYSIOLOGY;

DOBUTAMINE; HEART FAILURE, CONGESTIVE; HEMODYNAMICS; HUMAN; MYOCARDIAL CONTRACTION;

EID: 0023432807     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-198710000-00005     Document Type: Review

References (31)

1. N. Akhtar E. Mikulik J.N. Cohn M.H. Chaudhry Hemodynamic effect of dobutamine in patients with severe heart failure Am J Cardiol 36 1975 202 205
2. H.S. Loeb M. Khan M.L. Klodnycky Hemodynamic effects of dobutamine in man Circ Shock 2 1975 29 35
3. D. Jewitt A. Mitchell J. Birkhead C. Dollery Clinical cardiovascular pharmacology of dobutamine Lancet 2 1974 363 367
4. C.S. Liang V.V.B. Hood Dobutamine infusion in conscious dogs with and without autonomic nervous system inhibition: Effects of systemic hemodynamics, regional blood flows and cardiac metabolism J Pharmacol Exp Ther 211 1979 698 705
5. R.R. Ruffolo Jr. E.L. Morgan Interaction of the novel inotropic agent, ASL-7022, with a - and β-adrenoceptors in the cardiovascular system of the pithed rat: Comparison with dobutamine and dopamine J Pharmacol ExpTher 229 1984 364 371
6. C.V. Leier J. Webel C.A. Bush The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure Circulation 56 1977 468 472
7. E.H. Sonnenblick W.H. Frishman T.H. LeJemtel Dobutamine: A new synthetic cardioactive sympathetic amine N Engl J Med 300 1979 17 22
8. C.V. Leier P. Heban P. Huss C.A. Bush R.P. Lewis Comparative systemic regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic failure Circulation 58 1977 466 475
9. L.I. Goldberg Y.Y. Hsieh L. Resnekov Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamine Prog Cardiovasc Dis 19 1977 327 340
10. H.S. Loeb M. Khan A. Saudye Acute hemodynamic effects of dobutamine and isoproterenol in patients with low output cardiac failure Circ Shock 3 1971 55 63
11. R.R. Tuttle J. Mills Dobutamine: Development of a new catecholamine to selectively increase cardiac contractility Circ Res 36 1975 185 196
12. H.S. Loeb J. Bredakis R.M. Gunnar Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure Circulation 55 1977 375 381
13. C.V. Leier D.V. Unverferth Dobutamine Ann Intern Med 99 1983 490 496
14. N.H. Guiha J.N. Cohn E. Mikulic J.A. Franciosa C.J. Limas Treatment of refractory heart failure with infusion of nitro-prusside N Engl J Med 291 1974 587 592
15. K. Chatterjee W.W. Parmley The role of vasodilator therapy in heart failure ProgrCardiovasc 19 1977 301 325
16. E. Mikulic J.N. Cohn J.A. Franciosa Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure Circulation 56 1977 528 533
17. C. Berkowitz L. McKeever R.P. Croke Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure Circulation 56 1977 918 924
18. R.R. Ruffolo Jr. Drug, neurotransmitter and hormone receptors in the regulation of the cardiovascular system W.C. Shoemaker W.C. Thompson Critical Care State-of-the-Art 1983 Society of Critical Care Medicine K1 K56
19. R.R. Ruffolo Jr. K. Messick J.S. Horng Interaction of three inotropic agents, ASL-7022, dobutamine and dopamine, with a- and β-adrenoceptors in vitro Naunyn Schmeidebergs Arch Pharmacol 326 1984 317 326
20. R.R. Ruffolo Jr. E.L. Yaden Vascular effects of the stereoisomers of dobutamine J Pharmacol Exp Ther 224 1983 46 50
21. R.R. Ruffolo Jr. K. Messick Systemic hemodynamic effects of dopamine, (+)-dobutamine and the (+)- and (-)-enanti- omers of dobutamine in anesthetized normotensive rats Eur J Pharmacol 109 1985 173 181
22. R.R. Ruffolo Jr. T.A. Spradlin G.D. Pollock J.E. Waddell Murphy PJ: α- and β-adrenergic effects of the stereoisomers of dobutamine J Pharmacol Exp Ther 219 1981 447 452
23. P.J. Murphy T.L. Williams D.L.K. Kau Disposition of dobutamine in the dog J Pharmacol ExpTher 119 1976 423 431
24. R.R. Ruffolo Jr. K. Messick J.S. Horng Interactions of the enantiomers of 3-O-methyldobutamine with α- and β-adrenoceptors in vitro Naunyn Schmeidebergs Arch Pharmacol 329 1985 244 252
25. N.W. Robie D.O. Nutter C. Moody J.L. McNay In vivo analysis of adrenergic receptor activity of dobutamine Circ Res 34 1974 663 671
26. T.P. Kenakin An in vitro quantitative analysis of the α-adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity J Pharmacol ExpTher 216 1981 210 219
27. C. Maccarrone E. Malta Raper C: β-Adrenoceptor selectivity of dobutamine: In vivo and in vitro studies J Cardiovasc Pharmacol 6 1984 132 141
28. 3H-dihydroergocryptine binding Naunyn-Schmeideberg’s Arch Pharmacol 308 1979 191 198
29. H.J. Schumann Endoh M: α-Adrenoceptors in the ventricular myocardium: Clonidine, naphazoline and methoxamine as partial α-agonists exerting a competitive dualism in action to phenylephrine Eur J Pharmacol 36 1976 413 421
30. R.R. Ruffolo Jr. K. Messick Inotropic selectivity of dobutamine enantiomers in pithed rat J Pharmacol Exp Ther 235 1985 344 348
31. R.R. Ruffolo Jr. On the mechanism of action of dobutamine Ann Intern Med 100 1984 313 314